Precision therapy for invasive fungal diseases

Keyphrases

• Precision Medicine 100%
• Invasive Fungal Disease 100%
• Antifungal Drugs 100%
• Antifungal Therapy 100%
• Invasive Fungal Infection 50%
• Pharmacokinetics 50%
• Therapeutic Drug Monitoring 50%
• Pharmacodynamics 50%
• Cause of Death 50%
• Drug Exposure 50%
• Optimal Regimen 50%
• Fungal Infection 50%
• Invasive Aspergillosis 50%
• Infection-related 50%
• Current Therapies 50%
• Immunocompromised Patients 50%
• One-size-fits-all 50%
• In Vitro Susceptibility 50%
• Common Infections 50%
• Covenant 50%
• Susceptibility Breakpoints 50%

Medicine and Dentistry

• Antifungal Therapy 100%
• Antifungal Agent 100%
• Fungal Infection 100%
• In Vitro 50%
• Systemic Mycosis 50%
• Infection 50%
• Drug Exposure 50%
• Mycosis 50%
• Pharmacokinetics 50%
• Therapeutic Drug Monitoring 50%
• Invasive Aspergillosis 50%
• Immunocompromised Patient 50%
• Pharmacodynamics 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 100%
• Antifungal Agent 100%
• Antifungal Therapy 100%
• Therapeutic Drug Monitoring 50%
• Pharmacodynamics 50%
• Infection 50%
• Mycosis 50%
• Invasive Aspergillosis 50%
• Systemic Mycosis 50%
• Immunocompromised Patient 50%
• Pharmacokinetics 50%